Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients

Kuo Hsuan Hsu, Jeng Sen Tseng, Chih Liang Wang, Tsung Ying Yang, Chien Hua Tseng, Hsuan Yu Chen, Kun Chieh Chen, Chi Ren Tsai, Cheng Ta Yang, Sung Liang Yu, Kang Yi Su, Chong Jen Yu, Chao Chi Ho, Te Chun Hsia, Ming Fang Wu, Kuo Liang Chiu, Chien Ming Liu, Pan Chyr Yang, Jeremy J.W. Chen, Gee Chen Chang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Despite the advancement of epidermal growth factor receptor (EGFR) inhibitors in lung cancer therapy, it remains unclear whether EGFR mutation status in familial lung cancers is different from that of sporadic cases. In this multicenter retrospective study, we compared both the EGFR mutation frequency and patterns between familial and sporadic cases. The results explored that family history of lung cancer is an independent predictor for higher EGFR mutation rate in 1713 lung adenocarcinoma patients (Odd ratio 1.68, 95% CI 1.06-2.67, P = 0.028). However, the distribution of EGFR mutation subtypes was similar to that of sporadic cases. Part of our study involved 40 lung cancer families with at least 2 tumor tissues available within each single family (n = 88) and there was no familial aggregation pattern in EGFR mutation subtypes. There were two families harboring the YAP1 R331W germline risk allele and EGFR mutation statuses among YAP1 family members also varied. These phenomena may hint at the direction of future research into lung carcinogenesis and EGFR mutagenesis.

Original languageEnglish
Pages (from-to)53299-53308
Number of pages10
JournalOncotarget
Volume7
Issue number33
DOIs
Publication statusPublished - Aug 1 2016

Fingerprint

Epidermal Growth Factor Receptor
Lung Neoplasms
Mutation
Mutation Rate
Mutagenesis
Multicenter Studies
Carcinogenesis
Retrospective Studies
Alleles
Odds Ratio
Lung
Neoplasms

Keywords

  • Epidermal growth factor receptor (EGFR)
  • Familial lung cancer
  • Non-small cell lung cancer
  • YAP1

ASJC Scopus subject areas

  • Oncology

Cite this

Hsu, K. H., Tseng, J. S., Wang, C. L., Yang, T. Y., Tseng, C. H., Chen, H. Y., ... Chang, G. C. (2016). Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients. Oncotarget, 7(33), 53299-53308. https://doi.org/10.18632/oncotarget.10715

Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients. / Hsu, Kuo Hsuan; Tseng, Jeng Sen; Wang, Chih Liang; Yang, Tsung Ying; Tseng, Chien Hua; Chen, Hsuan Yu; Chen, Kun Chieh; Tsai, Chi Ren; Yang, Cheng Ta; Yu, Sung Liang; Su, Kang Yi; Yu, Chong Jen; Ho, Chao Chi; Hsia, Te Chun; Wu, Ming Fang; Chiu, Kuo Liang; Liu, Chien Ming; Yang, Pan Chyr; Chen, Jeremy J.W.; Chang, Gee Chen.

In: Oncotarget, Vol. 7, No. 33, 01.08.2016, p. 53299-53308.

Research output: Contribution to journalArticle

Hsu, KH, Tseng, JS, Wang, CL, Yang, TY, Tseng, CH, Chen, HY, Chen, KC, Tsai, CR, Yang, CT, Yu, SL, Su, KY, Yu, CJ, Ho, CC, Hsia, TC, Wu, MF, Chiu, KL, Liu, CM, Yang, PC, Chen, JJW & Chang, GC 2016, 'Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients', Oncotarget, vol. 7, no. 33, pp. 53299-53308. https://doi.org/10.18632/oncotarget.10715
Hsu, Kuo Hsuan ; Tseng, Jeng Sen ; Wang, Chih Liang ; Yang, Tsung Ying ; Tseng, Chien Hua ; Chen, Hsuan Yu ; Chen, Kun Chieh ; Tsai, Chi Ren ; Yang, Cheng Ta ; Yu, Sung Liang ; Su, Kang Yi ; Yu, Chong Jen ; Ho, Chao Chi ; Hsia, Te Chun ; Wu, Ming Fang ; Chiu, Kuo Liang ; Liu, Chien Ming ; Yang, Pan Chyr ; Chen, Jeremy J.W. ; Chang, Gee Chen. / Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients. In: Oncotarget. 2016 ; Vol. 7, No. 33. pp. 53299-53308.
@article{80a51945a3754ccbb3d59e4848a10ab6,
title = "Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients",
abstract = "Despite the advancement of epidermal growth factor receptor (EGFR) inhibitors in lung cancer therapy, it remains unclear whether EGFR mutation status in familial lung cancers is different from that of sporadic cases. In this multicenter retrospective study, we compared both the EGFR mutation frequency and patterns between familial and sporadic cases. The results explored that family history of lung cancer is an independent predictor for higher EGFR mutation rate in 1713 lung adenocarcinoma patients (Odd ratio 1.68, 95{\%} CI 1.06-2.67, P = 0.028). However, the distribution of EGFR mutation subtypes was similar to that of sporadic cases. Part of our study involved 40 lung cancer families with at least 2 tumor tissues available within each single family (n = 88) and there was no familial aggregation pattern in EGFR mutation subtypes. There were two families harboring the YAP1 R331W germline risk allele and EGFR mutation statuses among YAP1 family members also varied. These phenomena may hint at the direction of future research into lung carcinogenesis and EGFR mutagenesis.",
keywords = "Epidermal growth factor receptor (EGFR), Familial lung cancer, Non-small cell lung cancer, YAP1",
author = "Hsu, {Kuo Hsuan} and Tseng, {Jeng Sen} and Wang, {Chih Liang} and Yang, {Tsung Ying} and Tseng, {Chien Hua} and Chen, {Hsuan Yu} and Chen, {Kun Chieh} and Tsai, {Chi Ren} and Yang, {Cheng Ta} and Yu, {Sung Liang} and Su, {Kang Yi} and Yu, {Chong Jen} and Ho, {Chao Chi} and Hsia, {Te Chun} and Wu, {Ming Fang} and Chiu, {Kuo Liang} and Liu, {Chien Ming} and Yang, {Pan Chyr} and Chen, {Jeremy J.W.} and Chang, {Gee Chen}",
year = "2016",
month = "8",
day = "1",
doi = "10.18632/oncotarget.10715",
language = "English",
volume = "7",
pages = "53299--53308",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "33",

}

TY - JOUR

T1 - Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients

AU - Hsu, Kuo Hsuan

AU - Tseng, Jeng Sen

AU - Wang, Chih Liang

AU - Yang, Tsung Ying

AU - Tseng, Chien Hua

AU - Chen, Hsuan Yu

AU - Chen, Kun Chieh

AU - Tsai, Chi Ren

AU - Yang, Cheng Ta

AU - Yu, Sung Liang

AU - Su, Kang Yi

AU - Yu, Chong Jen

AU - Ho, Chao Chi

AU - Hsia, Te Chun

AU - Wu, Ming Fang

AU - Chiu, Kuo Liang

AU - Liu, Chien Ming

AU - Yang, Pan Chyr

AU - Chen, Jeremy J.W.

AU - Chang, Gee Chen

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Despite the advancement of epidermal growth factor receptor (EGFR) inhibitors in lung cancer therapy, it remains unclear whether EGFR mutation status in familial lung cancers is different from that of sporadic cases. In this multicenter retrospective study, we compared both the EGFR mutation frequency and patterns between familial and sporadic cases. The results explored that family history of lung cancer is an independent predictor for higher EGFR mutation rate in 1713 lung adenocarcinoma patients (Odd ratio 1.68, 95% CI 1.06-2.67, P = 0.028). However, the distribution of EGFR mutation subtypes was similar to that of sporadic cases. Part of our study involved 40 lung cancer families with at least 2 tumor tissues available within each single family (n = 88) and there was no familial aggregation pattern in EGFR mutation subtypes. There were two families harboring the YAP1 R331W germline risk allele and EGFR mutation statuses among YAP1 family members also varied. These phenomena may hint at the direction of future research into lung carcinogenesis and EGFR mutagenesis.

AB - Despite the advancement of epidermal growth factor receptor (EGFR) inhibitors in lung cancer therapy, it remains unclear whether EGFR mutation status in familial lung cancers is different from that of sporadic cases. In this multicenter retrospective study, we compared both the EGFR mutation frequency and patterns between familial and sporadic cases. The results explored that family history of lung cancer is an independent predictor for higher EGFR mutation rate in 1713 lung adenocarcinoma patients (Odd ratio 1.68, 95% CI 1.06-2.67, P = 0.028). However, the distribution of EGFR mutation subtypes was similar to that of sporadic cases. Part of our study involved 40 lung cancer families with at least 2 tumor tissues available within each single family (n = 88) and there was no familial aggregation pattern in EGFR mutation subtypes. There were two families harboring the YAP1 R331W germline risk allele and EGFR mutation statuses among YAP1 family members also varied. These phenomena may hint at the direction of future research into lung carcinogenesis and EGFR mutagenesis.

KW - Epidermal growth factor receptor (EGFR)

KW - Familial lung cancer

KW - Non-small cell lung cancer

KW - YAP1

UR - http://www.scopus.com/inward/record.url?scp=84982274274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982274274&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.10715

DO - 10.18632/oncotarget.10715

M3 - Article

C2 - 27449093

AN - SCOPUS:84982274274

VL - 7

SP - 53299

EP - 53308

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 33

ER -